Integrative analysis of transcriptome and metabolome provide new insights into mechanisms of Capilliposide A against cisplatin-induced nephrotoxicity
Jiaxi Fang(Zhejiang Chinese Medical University), Wei Zhu(Ministry of Education of the People's Republic of China), Yan Liang(Zhejiang University), Qiang He(State Key Laboratory of Silkworm Genomic Biology), Luping Wang(Zhejiang Chinese Medical University), Jingkui Tian(Zhejiang Cancer Hospital), Shouxin Li(Chinese Academy of Sciences), Di Zhang(Zhejiang Provincial People's Hospital), Juan Jin(First Affiliated Hospital of Heilongjiang University of Chinese Medicine)
Cited by 6
Related Papers
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
|PLoS ONE|2012|196
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
|Annals of the Rheumatic Diseases|2013|168